TY  - GEN
AU  - Olfat,M
AU  - Silverman,E D
AU  - Levy,D M
TI  - Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus
SN  - 1477-0962
PY  - 2016///0608
KW  - Adolescent
KW  - Agammaglobulinemia
KW  - drug therapy
KW  - Age of Onset
KW  - Anemia, Hemolytic, Autoimmune
KW  - blood
KW  - Antirheumatic Agents
KW  - adverse effects
KW  - B-Lymphocytes
KW  - immunology
KW  - Child
KW  - Cohort Studies
KW  - Female
KW  - Humans
KW  - Immunoglobulins, Intravenous
KW  - therapeutic use
KW  - Immunophenotyping
KW  - Lupus Erythematosus, Systemic
KW  - Male
KW  - Purpura, Thrombocytopenic, Idiopathic
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Rituximab
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1177/0961203315578764
ER  -